Preferences for the provision of oral and injectable PrEP among MSM and transgender persons who discontinued oral PrEP in Europe

AUTHORS

H. Zimmermann¹, H. Wang¹, J. Kolstee¹, A. Adriaque Lozano¹, M. Schroeder², A. Appiah², C. Brown³, J. Scherzer⁴, K. Jonas¹


INSTITUTIONS

¹Maastricht University, Work and Social Psychology, Maastricht, Netherlands, the, ²ViiV Healthcare Ltd, Brentford, United Kingdom, ³ViiV Healthcare Ltd, Durham, United States, ⁴ViiV Healthcare Ltd, Munich, Germany